Industry NewsNirsevimab reduced respiratory syncytial virus infections and hospitalizations in preterm infants in Phase IIb trial
Industry NewsTecan expands presence in the US with new distribution agreement for detection instruments
Expert InsightsRapid and functional evaluation of virus-neutralizing antibodies using multi-parametric live cell analysis
Industry NewsFDA approves GSK’s BLENREP for the treatment of patients with relapsed or refractory multiple myeloma